Diversified applications of hepatocellular carcinoma medications: molecular-targeted, immunotherapeutic, and combined approaches

Hepatocellular carcinoma (HCC) is one of the primary forms of liver cancer and is currently the sixth most prevalent malignancy worldwide. In addition to surgical interventions, effective drug treatment is essential for treating HCC. With an increasing number of therapeutic drugs for liver cancer un...

Full description

Bibliographic Details

Published in:	Frontiers in Pharmacology
Main Authors:	Haoyang Chen, Huihui Liu, Xiaowei Zhang, Suhua Wang, Chunxia Liu, Ke An, Ruijuan Liu, Xin Tian
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-09-01
Subjects:	hepatocellular carcinoma molecular-targeted drugs sorafenib immunotherapeutic agents combination therapies
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1422033/full